JPWO2022245933A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022245933A5 JPWO2022245933A5 JP2023572110A JP2023572110A JPWO2022245933A5 JP WO2022245933 A5 JPWO2022245933 A5 JP WO2022245933A5 JP 2023572110 A JP2023572110 A JP 2023572110A JP 2023572110 A JP2023572110 A JP 2023572110A JP WO2022245933 A5 JPWO2022245933 A5 JP WO2022245933A5
- Authority
- JP
- Japan
- Prior art keywords
- testosterone
- subject
- serum level
- steady
- daily
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163190609P | 2021-05-19 | 2021-05-19 | |
| US63/190,609 | 2021-05-19 | ||
| PCT/US2022/029819 WO2022245933A1 (en) | 2021-05-19 | 2022-05-18 | Preferred oral testosterone undecanoate therapy to achieve testosterone replacement treatment |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024521127A JP2024521127A (ja) | 2024-05-28 |
| JPWO2022245933A5 true JPWO2022245933A5 (https=) | 2025-05-27 |
| JP2024521127A5 JP2024521127A5 (https=) | 2025-05-27 |
Family
ID=84140782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023572110A Pending JP2024521127A (ja) | 2021-05-19 | 2022-05-18 | テストステロン補充治療を実現するための好ましい経口ウンデカン酸テストステロン療法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230398128A1 (https=) |
| EP (1) | EP4340846A4 (https=) |
| JP (1) | JP2024521127A (https=) |
| KR (1) | KR20240027602A (https=) |
| AU (2) | AU2022277557B2 (https=) |
| BR (1) | BR112023024162A2 (https=) |
| CA (1) | CA3219547A1 (https=) |
| IL (1) | IL308658A (https=) |
| MX (1) | MX2023013734A (https=) |
| WO (1) | WO2022245933A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2519230T3 (pl) | 2009-12-31 | 2019-05-31 | Marius Pharmaceuticals Llc | Modulacja rozpuszczalności, stabilności, absorpcji, metabolizmu i profilu farmakokinetycznego leków lipofilowych przez sterole |
| EP2968137B1 (en) | 2013-03-15 | 2021-11-10 | Marius Pharmaceuticals LLC | Emulsion formulations |
| US12403146B2 (en) | 2019-10-30 | 2025-09-02 | Marius Pharmaceuticals, Inc. | Preferred oral testosterone undecanoate therapy to achieve testosterone replacement treatment |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2519230T3 (pl) * | 2009-12-31 | 2019-05-31 | Marius Pharmaceuticals Llc | Modulacja rozpuszczalności, stabilności, absorpcji, metabolizmu i profilu farmakokinetycznego leków lipofilowych przez sterole |
| US20200197412A1 (en) * | 2018-12-20 | 2020-06-25 | Clarus Therapeutics, Inc. | Methods of treating testosterone deficiency |
| US11564933B2 (en) * | 2019-04-12 | 2023-01-31 | Tolmar, Inc. | Methods of treating testosterone deficiency |
-
2022
- 2022-05-18 KR KR1020237043696A patent/KR20240027602A/ko active Pending
- 2022-05-18 MX MX2023013734A patent/MX2023013734A/es unknown
- 2022-05-18 JP JP2023572110A patent/JP2024521127A/ja active Pending
- 2022-05-18 AU AU2022277557A patent/AU2022277557B2/en active Active
- 2022-05-18 BR BR112023024162A patent/BR112023024162A2/pt not_active Application Discontinuation
- 2022-05-18 EP EP22805390.6A patent/EP4340846A4/en active Pending
- 2022-05-18 CA CA3219547A patent/CA3219547A1/en active Pending
- 2022-05-18 WO PCT/US2022/029819 patent/WO2022245933A1/en not_active Ceased
- 2022-05-18 IL IL308658A patent/IL308658A/en unknown
-
2023
- 2023-05-24 US US18/201,498 patent/US20230398128A1/en active Pending
-
2024
- 2024-10-31 AU AU2024227786A patent/AU2024227786A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hadorn et al. | Pancreozymin secretin test of exocrine pancreatic funtion in cystic fribrosis and the significance of the result for the pathogenesis of the disease | |
| JP2005525308A5 (https=) | ||
| US6166017A (en) | Method of using ketoconazole and related substances in medicaments for treatment of type II diabetes and methods of treating same | |
| RU2012117563A (ru) | Режим дозирования модулятора рецептора s1p | |
| JP2003510275A (ja) | ロテプレドノールと抗ヒスタミン薬の新規な組み合わせ物 | |
| JP2012522816A (ja) | 改良されたグルココルチコイド療法 | |
| KR20210057758A (ko) | 간 질환을 치료하기 위한 병용 요법 | |
| US20250213504A1 (en) | Methods of intravenously administering sotalol hydrochloride for the treatment of pediatric patients | |
| PT1272177E (pt) | Método e formulação para o tratamento da resistência aos antihipertensos e condições associadas. | |
| JP2006514665A5 (https=) | ||
| WO2008073779A2 (en) | Compositions and methods for treating seizures | |
| JPWO2022245933A5 (https=) | ||
| US20250281448A1 (en) | Cardioversion Methods Using Budiodarone | |
| US11033603B2 (en) | Method for treating ocular diseases | |
| EP2723348B1 (en) | Method for treating obesity | |
| US6642236B1 (en) | Methods for prophylactic treatment of cardiovascular disease with inhibitor of cortisol synthesis | |
| JP3885135B2 (ja) | Ｃ型又は非ｂ非ｃ型肝炎ウイルスによる肝機能異常の改善剤 | |
| RU2555752C2 (ru) | Лечение вагинальной атрофии у женщин с риском сердечно-сосудистой патологии | |
| US20240009433A1 (en) | Methods for continuous oral drug delivery | |
| JPWO2022249071A5 (https=) | ||
| Rodríguez-García | When Should I Consider Using Systemic Corticosteroids to Treat Uveitis? | |
| JP3627801B2 (ja) | 副鼻腔炎の予防および／または治療剤 | |
| JPS58150514A (ja) | 脂質代謝改善剤 | |
| JPWO2023004151A5 (https=) | ||
| CN120093761A (zh) | 一种治疗冠心病的药物组合物 |